AtaiBeckley Inc. (ATAI)
ATAI · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2025
Who owns AtaiBeckley Inc.
As filed with the SECHolders of 5% or more
1
Blackrock, Inc. holds 6.8% of Common Stock, as its SCHEDULE 13G filed Jul 27, 2026 says.
Directors and officers
16
report now, of 16 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G · filed Jul 27, 2026 · Common Stock
Apeiron Investment Group Ltd.
SCHEDULE 13D/A · filed Sep 14, 2026 · Common stock, par value $0.01 per share · reported falling below 5%, from 15.4% in Jul 17, 2026
What ATAI reports owning in othersstakes of 5% or more, and other ties
COMPASS Pathways Plc American Depository Shares CMPS
SCHEDULE 13D/A · filed Feb 17, 2026 · Ordinary Shares · reported falling below 5%
Other ties the annual report names
Beckley Psytech Limited
An investee · investee · invested in, named in the 10-K filed Mar 6, 2026
Compass Pathways Plc
An investee · investee · invested in, named in the 10-K filed Mar 6, 2026
GABA Therapeutics Inc
An investee · investee · invested in, named in the 10-K filed Mar 6, 2026
Kures
An investee · investee · invested in, named in the 10-K filed Mar 6, 2026
Beckley Psytech
A company bought · asset acquisition · owns, named in the 10-K filed Mar 6, 2026
IntelGenx Corp
A company bought · acquisition · owns, named in the 10-K filed Mar 6, 2026
Nualtis Corp
A company bought · asset acquisition · owns, named in the 10-K filed Mar 6, 2026
11 subsidiaries in 4 countries, from the list filed with the 10-K filed Mar 6, 2026.
Insider tradesForm 4
6sales
0purchases
5sales on a scheduled plan
4people selling
$1.7Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 17 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Craig Kevin James | Chief Medical Officer | 3 | $800,000 | 3 | 0 | $0 |
| Hershberg Robert | director | 1 | $500,000 | 1 | 0 | $0 |
| Kochendoerfer Gerd | Chief Operating Officer | 1 | $300,000 | 1 | 0 | $0 |
| Feilding-Mellen Cosmo | director | 1 | $200,000 | 0 | 0 | $0 |